Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression
- PMID: 19545857
- PMCID: PMC2935847
- DOI: 10.1016/j.biopsych.2009.04.029
Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression
Abstract
Background: Intravenous ketamine has shown rapid antidepressant effects in early trials, making it a potentially attractive candidate for depressed patients at imminent risk of suicide. The Implicit Association Test (IAT), a performance-based measure of association between concepts, may have utility in suicide assessment.
Methods: Twenty-six patients with treatment-resistant depression were assessed using the suicidality item of the Montgomery-Asberg Depression Rating Scale (MADRS-SI) 2 hours before and 24 hours following a single subanesthetic dose of intravenous ketamine. Ten patients also completed IATs assessing implicit suicidal associations at comparable time points. In a second study, nine patients received thrice-weekly ketamine infusions over a 12-day period.
Results: Twenty-four hours after a single infusion, MADRS-SI scores were reduced on average by 2.08 points on a 0 to 6 scale (p < .001; d = 1.37), and 81% of patients received a rating of 0 or 1 postinfusion. Implicit suicidal associations were also reduced following ketamine (p = .003; d = 1.36), with reductions correlated across implicit and explicit measures. MADRS-SI reductions were sustained for 12 days by repeated-dose ketamine (p < .001; d = 2.42).
Conclusions: These preliminary findings support the premise that ketamine has rapid beneficial effects on suicidal cognition and warrants further study.
Trial registration: ClinicalTrials.gov NCT00419003 NCT00548964.
Figures
Similar articles
-
Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depression.Depress Anxiety. 2014 Apr;31(4):335-43. doi: 10.1002/da.22253. Epub 2014 Mar 25. Depress Anxiety. 2014. PMID: 24668760 Free PMC article. Clinical Trial.
-
Single and repeated ketamine infusions for reduction of suicidal ideation in treatment-resistant depression.Neuropsychopharmacology. 2020 Mar;45(4):606-612. doi: 10.1038/s41386-019-0570-x. Epub 2019 Nov 23. Neuropsychopharmacology. 2020. PMID: 31759333 Free PMC article. Clinical Trial.
-
Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial.Am J Psychiatry. 2019 May 1;176(5):401-409. doi: 10.1176/appi.ajp.2018.18070834. Epub 2019 Mar 29. Am J Psychiatry. 2019. PMID: 30922101 Clinical Trial.
-
The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis.Am J Psychiatry. 2018 Feb 1;175(2):150-158. doi: 10.1176/appi.ajp.2017.17040472. Epub 2017 Oct 3. Am J Psychiatry. 2018. PMID: 28969441 Free PMC article. Review.
-
Ketamine as a potential treatment for suicidal ideation: a systematic review of the literature.Drugs R D. 2015 Mar;15(1):37-43. doi: 10.1007/s40268-015-0081-0. Drugs R D. 2015. PMID: 25773961 Free PMC article. Review.
Cited by
-
Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder.Mol Psychiatry. 2015 Oct;20(10):1142-50. doi: 10.1038/mp.2015.92. Epub 2015 Jul 7. Mol Psychiatry. 2015. PMID: 26148812 Review.
-
Current Trends in Identifying Rapidly Acting Treatments for Depression.Curr Behav Neurosci Rep. 2016 Jun;3(2):185-191. doi: 10.1007/s40473-016-0075-4. Epub 2016 Apr 15. Curr Behav Neurosci Rep. 2016. PMID: 27574579 Free PMC article.
-
Intranasal Delivery of Ketamine Induces Cortical Disinhibition.eNeuro. 2024 Jan 17;11(1):ENEURO.0107-23.2023. doi: 10.1523/ENEURO.0107-23.2023. Print 2024 Jan. eNeuro. 2024. PMID: 38164560 Free PMC article.
-
Postoperative delirium and cognitive dysfunction.Br J Anaesth. 2009 Dec;103 Suppl 1(Suppl 1):i41-46. doi: 10.1093/bja/aep291. Br J Anaesth. 2009. PMID: 20007989 Free PMC article. Review.
-
Regular exercise and creatine supplementation prevent chronic mild stress-induced decrease in hippocampal neurogenesis via Wnt/GSK3β/β-catenin pathway.J Exerc Nutrition Biochem. 2018 Jun 30;22(2):1-6. doi: 10.20463/jenb.2018.0009. J Exerc Nutrition Biochem. 2018. PMID: 30149419 Free PMC article.
References
-
- Szanto K, Mulsant BH, Houck P, Dew MA, Reynolds CF., 3rd Occurrence and course of suicidality during short-term treatment of late-life depression. Arch Gen Psychiatry. 2003;60:610–617. - PubMed
-
- Busch KA, Fawcett J, Jacobs DG. Clinical correlates of inpatient suicide. Journal of Clinical Psychiatry. 2003;64:14–19. - PubMed
-
- Greenwald AG, McGhee DE, Schwartz JL. Measuring individual differences in implicit cognition: the implicit association test. J Pers Soc Psychol. 1998;74:1464–1480. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
